87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up

作者
Ann E. Woolley,Hilary J. Goldberg,Steve K. Singh,Mandeep R. Mehra,Michael M. Givertz,Antonio Coppolino,Vivien Cheng,John R. Fanikos,David P. Harrington,Hari Reddy Mallidi,Lindsey Robert Baden
出处
期刊:Open Forum Infectious Diseases [Oxford University Press]
卷期号:6 (Supplement_2): S5-S5 被引量:2
标识
DOI:10.1093/ofid/ofz359.011
摘要

Abstract Background The DONATE HCV Trial demonstrated that hearts and lungs can be safely transplanted from HCV-infected donors using a shortened, 4-week, pre-emptive course of direct-acting antivirals (DAA). The 6-month results from that study of 35 patients are encouraging, but longer-term data from a larger cohort are needed to better define the risk–benefit profile. Methods We conducted a single-center trial to transplant thoracic organs from HCV viremic donors, irrespective of HCV genotype, to HCV-uninfected adults. Sofosbuvir/velpatasvir, a pan-genotypic DAA, was pre-emptively administered for 4 weeks, beginning within hours of transplant. The primary outcome was a composite of HCV clearance and graft survival at 6 months post-transplant. Secondary outcomes included graft survival and mortality at 12 months and the occurrence of grade 3 or higher adverse events (AEs). This protocol is IRB approved and all participants provided written informed consent (NCT03086044). Results Between March 2017 and March 2019, 57 participants were enrolled: 46 received lung and 11 received heart transplants. The median donor HCV viral load (VL) was 889,817 IU/mL (IQR 212,062–4,641,078). Of the 57 recipients, 53 (93%) had detectable HCV VL immediately after transplant, with median VL of 1,460 IU/mL (IQR 463–6,618). HCV VL became negative by about 2 weeks and subsequently remained undetectable in all participants. Forty-nine of 49 (100%) and 34 of 35 (97%) participants were alive with excellent graft function and an undetectable HCV VL at 6 months and 1-year post-transplant, respectively. No treatment-related serious AEs were identified. Outcomes between transplant recipients from HCV donors vs. non-HCV donors were similar, including the occurrence of renal failure, respiratory failure, and non-HCV infections. Conclusion In patients who received thoracic organs from HCV viremic donors, a 4-week antiviral treatment course initiated within hours of transplant prevented the establishment of HCV infection. These data demonstrate that thoracic organs from HCV viremic donors can be transplanted safely with excellent graft and recipient survival at 12 months with a similar AE profile compared with transplant recipients who received thoracic organs from non-HCV donors. Two-year outcomes will be available in October 2019. Disclosures All Authors: No reported Disclosures.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
2秒前
weitao0916完成签到,获得积分10
2秒前
冬冬完成签到,获得积分10
3秒前
小蘑菇的应助被杨淼采纳,获得10
3秒前
爱听歌的沛儿完成签到 ,获得积分20
3秒前
3秒前
4秒前
5秒前
李健的小迷弟的应助被晓天采纳,获得10
5秒前
张伟的应助被钱罐罐采纳,获得10
5秒前
Zzha10发布了新的文献求助10
5秒前
5秒前
是我呀吼发布了新的文献求助20
6秒前
Orange的应助被土豪的城采纳,获得30
8秒前
XS_QI发布了新的文献求助10
8秒前
还有早安完成签到,获得积分10
8秒前
安详的夜春完成签到,获得积分10
8秒前
小鱼干完成签到,获得积分10
8秒前
自由的王发布了新的文献求助10
9秒前
开朗紫发布了新的文献求助10
9秒前
叶95完成签到,获得积分10
10秒前
10秒前
11秒前
11秒前
Maestro_S的应助被小鱼干采纳,获得10
12秒前
12秒前
吕锴岐完成签到 ,获得积分10
13秒前
huang完成签到 ,获得积分10
13秒前
13秒前
zjjcug完成签到,获得积分10
13秒前
苦昼短完成签到 ,获得积分10
13秒前
zzl完成签到,获得积分10
13秒前
大个的应助被小青采纳,获得10
14秒前
anqi6688完成签到,获得积分10
14秒前
Zzha10完成签到,获得积分10
14秒前
CarryLJR发布了新的文献求助10
14秒前
充电宝的应助被生而追梦不止采纳,获得10
15秒前
张伟的应助被漫漫采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568